Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$137K Sell
11,166
-16,465
-60% -$264K ﹤0.01% 417
2026
Q2
$465K Buy
+27,631
New +$465K 0.01% 258
2025
Q3
– Sell
-12,790
Closed -$178K – 312
2025
Q2
$178K Buy
+12,790
New +$208K 0.01% 305
2018
Q4
– Sell
-5,578
Closed -$257K – 247
2018
Q3
$257K Buy
+5,578
New +$248K 0.02% 209

Other funds holding PCG

Aspiriant LLC's PCG Position: Q3 2026 in Review

Aspiriant LLC reduced its PG&E (PCG) stake by 60% in Q3 2026, selling an estimated $264K and leaving 11,166 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

Aspiriant LLC first reported a position in PCG in Q3 2018 and has held it in 4 quarters since. The position peaked at $465K in Q2 2026. 119 funds tracked by Wall St. Rank hold PCG as of Q3 2026.

  • Aspiriant LLC held 11,166 shares of PG&E worth $137K as of Q3 2026.
  • Aspiriant LLC sold 16,465 PG&E shares in Q3 2026, an estimated $264K.
  • PG&E made up ﹤0.01% of Aspiriant LLC's portfolio in Q3 2026, its #417 holding.
  • Aspiriant LLC first reported a position in PG&E in Q3 2018 and has held it in 4 quarters since.
  • Aspiriant LLC's PG&E position peaked at $465K in Q2 2026.
  • 119 funds tracked by Wall St. Rank held PG&E as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.